blindness from glp 1 Doctor Explains Risk (Should You Be Worried?) Ozempic Blindness: Should You Worry?

In addition, our data unambiguously documented that the effects of this and other multi-functional analogs on body weight and food intake are not merely due to food aversion or malaise linked to gastrointestinal distress, regarded as one of the main side-effects of GLP1-based therapy in humans 49

doi: 10.1016/j.foodchem.2017.01.056 200 WeiC-KTsaiY-HKorinekMHungP-HEl-ShazlyMChengY-Bet al

While theoretically concerning, existing data suggest that combination agents using glucagon agonism do not produce greater-than-expected contractile muscle loss

Glucagon-like peptide-1 receptor agonists in the treatment of idiopathic inflammatory myopathy: from mechanisms of action to clinical applications

This can include doctors, nutritionists, and other certified medical staff